X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) IPO

X4 Pharmaceuticals, Inc.

IPO

Went public as Arsanis, Inc. Priced at US$10.00 a share on Nov 15, 2017.

Price
US$10.00 a share
Shares offered
4,000,000 shares of common stock
Offering size
US$40 million
Underwriters' option
Up to 600,000 more shares
Underwriters
Citigroup, Cowen, Piper Jaffray · In the order on the cover
Shares delivered
On or about Nov 20, 2017

Steps

StepWhen
Draft sent to the SEC in confidenceAug 10, 2017
Filed publiclyOct 20, 2017
Amended twiceNewest Nov 15, 2017
Shares registered with an exchangeNov 15, 2017
Declared effective by the SECNov 15, 2017
Final prospectus, with the priceNov 17, 2017

From the cover of the final prospectus (424B1) filed Nov 17, 2017